Metabolite Changes Track Muscle Decline in Eight-Month Space Analog Mission

Scientists monitoring five volunteers who spent eight months in isolation and confinement as part of the SIRIUS-21 space analog mission have identified a set of metabolites in blood and saliva that changed in step with declining muscle function. The study, published in Frontiers in Network Physiology, combined longitudinal metabolomic profiling with electromyography (EMG) assessments to explore molecular signatures associated with muscle dysfunction during prolonged confinement. During the eight-month mission, five participants, three males and two females, provided plasma and saliva samples and underwent EMG assessments at five time points: at baseline before entering the facility (Ingress), during the early, mid, and late phases of isolation and confinement (IC), and 14 days after leaving the mission (Egress).

Metabolites were analyzed using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The researchers assessed longitudinal metabolite changes with repeated-measures ANOVA and Tukey HSD post hoc testing, and explored direct relationships between metabolites and EMG metrics using Spearman rank correlations. The metabolomic profiling identified 45 skeletal muscle-related metabolites with nominally significant longitudinal changes, with p values ranging from less than 0.0001 to 0.05.

Of these, eight metabolites were detected in both plasma and saliva, 26 only in plasma, and 11 only in saliva. Exploratory Spearman correlations with EMG metrics were found for a subset of metabolites, including pipecolic acid, phenylacetic acid, L-phenylalanine, L-acetylcarnitine, L-glutamine, and pyruvaldehyde. The correlations are exploratory and do not by themselves demonstrate that the metabolites cause the observed functional changes.

The EMG measurements showed a progressive decline in muscle activation and fatigue resistance as the isolation and confinement period wore on, followed by partial recovery after the participants exited the mission. This pattern indicates that the functional consequences of prolonged confinement were not fully reversed within two weeks of returning to normal conditions in this small cohort. The team also carried out exploratory analyses of sex-related differences in the metabolite and EMG data.

Because the cohort included only two females and three males, these analyses were interpreted descriptively only, and no firm conclusions about sex-specific responses can be drawn from this study. The authors are explicit that the identified metabolites represent candidate metabolic signatures associated with muscle dysfunction and require validation in larger independent cohorts before any diagnostic or therapeutic utility can be established. The study's design has clear strengths and limitations.

Repeated sampling at five time points across an eight-month mission, with paired metabolomic and functional measurements, allows within-person trajectories to be tracked rather than relying on single snapshots. On the other hand, the sample of five participants is very small, all findings are nominally significant rather than corrected for multiple comparisons across many metabolites, and the correlations with EMG metrics are exploratory. The authors frame the work as showing that prolonged isolation and confinement was accompanied by coordinated changes in muscle function and circulating or salivary metabolites.

For now, the study stands as a carefully documented first step: coordinated changes in muscle function and metabolite levels during eight months of confinement, with partial recovery after egress, and a defined list of metabolites for future validation studies to test.

Subject of Research: Metabolomic biomarkers of muscle dysfunction during prolonged isolation and confinement in the SIRIUS-21 space analog mission

Article Title: Metabolomic signatures associated with muscle dysfunction during the SIRIUS-21 space analog mission

Article References: Elmoselhi, A. B., Taylor, C., Shankhwar, V., Blaber, A., Ibrahim, Z., Al-Hroub, H. M., Soares, N. C., & Goswami, N. (2026). Metabolomic signatures associated with muscle dysfunction during the SIRIUS-21 space analog mission. Frontiers in Network Physiology, 6, Article 1970105. https://doi.org/10.3389/fnetp.2026.1970105

Image Credits: AI Generated

DOI: 10.3389/fnetp.2026.1970105

Keywords: SIRIUS-21, space analog mission, isolation and confinement, metabolomics, skeletal muscle, electromyography, muscle fatigue, biomarkers, LC-MS/MS, spaceflight physiology, Metabolomic, signatures